Trials / Withdrawn
WithdrawnNCT03498014
Comparison of Standard Opioid Prescription Versus Prescription Guided by Pharmacogenetic Analysis in Patients With Non-cancerous Chronic Pain.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that opioid prescription guided by patient pharmacogenetic profile will diminish opioid-associated undesirable effects by 50% and improve medication compliance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pharmacogenetic analysis allowing personalized opioid prescription | Genotypic of patient to determine optimal opioid treatment (tramadol, codeine or oxycodone) |
| OTHER | Standard opioid prescription | Opioid prescription made without reference to patient genetic profile (tramadol, codeine or oxycodone) |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2018-04-13
- Last updated
- 2023-02-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03498014. Inclusion in this directory is not an endorsement.